« Back Journal of Dermatological Science

Article in Press

Histological and transcriptional study of angiogenesis and lymphangiogenesis in uninvolved skin, acute pinpoint lesions and established psoriasis plaques: An approach of vascular development chronology in psoriasis

  • Audrey Henno

      Affiliations

    • Department of Dermatology, University Hospital of Liège, Belgium
    • Laboratory of Connective Tissues Biology, GIGA-R, 4000 Liège, Belgium
    • Corresponding Author InformationCorresponding author at: Laboratory of Connective Tissues Biology, Centre Hospitalier Universitaire de Liège, B 23, B-4000 Sart Tilman, Belgium. Tel.: +32 43662469; fax: +32 43662457.
    • ,
  • Silvia Blacher

      Affiliations

    • Laboratory of Tumor and Development Biology, GIGA-R, University of Liège B23, 4000 Liège, Belgium
    • ,
  • Charles A. Lambert

      Affiliations

    • Laboratory of Connective Tissues Biology, GIGA-R, 4000 Liège, Belgium
    • ,
  • Christophe Deroanne

      Affiliations

    • Laboratory of Connective Tissues Biology, GIGA-R, 4000 Liège, Belgium
    • ,
  • Agnès Noël

      Affiliations

    • Laboratory of Tumor and Development Biology, GIGA-R, University of Liège B23, 4000 Liège, Belgium
    • ,
  • Charles Lapière

      Affiliations

    • Laboratory of Connective Tissues Biology, GIGA-R, 4000 Liège, Belgium
    • ,
  • Michel de la Brassinne

      Affiliations

    • Department of Dermatology, University Hospital of Liège, Belgium
    • ,
  • Betty V. Nusgens

      Affiliations

    • Laboratory of Connective Tissues Biology, GIGA-R, 4000 Liège, Belgium
    • ,
  • Alain Colige

      Affiliations

    • Laboratory of Connective Tissues Biology, GIGA-R, 4000 Liège, Belgium

Received 30 July 2009 ,Revised 3 December 2009 ,Accepted 9 December 2009. Published online 12 July 2010 Corrected Proof

References 

  1. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263–271
  2. Braverman IM, Yen A. Ultrastructure of the capillary loops in the dermal papillae of psoriasis. J Invest Dermatol. 1977;68:53–60
  3. de la Brassinne M, Lachapelle JM. 3H-thymidine labelling of epidermis and dermal infiltrate in psoriatic erythroderma. Acta Derm Venereol. 1975;55:171–174
  4. Creamer D, Sullivan D, Bicknell R, Barker J. Angiogenesis in psoriasis. Angiogenesis. 2002;5:231–236
  5. Lowe PM, Lee ML, Jackson CJ, To SS, Cooper AJ, Schrieber L. The endothelium in psoriasis. Br J Dermatol. 1995;132:497–505
  6. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007;8:464–478
  7. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med. 1994;180:1141–1146
  8. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669–676
  9. Mineur P, Colige AC, Deroanne CF, Dubail J, Kesteloot F, Habraken Y, et al. Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents. J Cell Biol. 2007;179:1261–1273
  10. Henno A, Blacher S, Lambert C, Colige A, Seidel L, Noel A, et al. Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis. Br J Dermatol. 2009;160:581–590
  11. Cianfarani F, Zambruno G, Brogelli L, Sera F, Lacal PM, Pesce M, et al. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am J Pathol. 2006;169:1167–1182
  12. Oura H, Bertoncini J, Velasco P, Brown LF, Carmeliet P, Detmar M. A critical role of placental growth factor in the induction of inflammation and edema formation. Blood. 2003;101:560–567
  13. Cao Y, Ji WR, Qi P, Rosin A. Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem Biophys Res Commun. 1997;235:493–498
  14. Yang W, Ahn H, Hinrichs M, Torry RJ, Torry DS. Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells. J Reprod Immunol. 2003;60:53–60
  15. Oliver G, Detmar M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 2002;16:773–783
  16. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004;5:74–80
  17. Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor. VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J. 2000;14:2087–2096
  18. Favier B, Alam A, Barron P, Bonnin J, Laboudie P, Fons P, et al. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood. 2006;108:1243–1250
  19. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol. 2004;25:387–395
  20. Hong YK, Harvey N, Noh YH, Schacht V, Hirakawa S, Detmar M, et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn. 2002;225:351–357
  21. Kunstfeld R, Hirakawa S, Hong YK, Schacht V, Lange-Asschenfeldt B, Velasco P, et al. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood. 2004;104:1048–1057
  22. Henno A, Lapiere CM, Nusgens BV, de la Brassinne M. Lymphatic vasculature: dermatological implications of emerging concepts. Ann Dermatol Venereol. 2008;135:704–709
  23. Christophers E, Parzefall R, Braun-Falco O. Initial events in psoriasis: quantitative assessment. Br J Dermatol. 1973;89:327–334
  24. Braun-Falco O, Christophers E. Structural aspects of initial psoriatic lesions. Arch Dermatol Forsch. 1974;251:95–110
  25. Braun-Falco O, Schmoeckel C. The dermal inflammatory reaction in initial psoriatic lesions. Arch Dermatol Res. 1977;258:9–16
  26. Chowaniec O, Jablonska S, Beutner EH, Proniewska M, Jarzabek-Chorzelska M, Rzesa G. Earliest clinical and histological changes in psoriasis. Dermatologica. 1981;163:42–51
  27. Nusgens BV, Humbert P, Rougier A, Colige AC, Haftek M, Lambert CA, et al. Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J Invest Dermatol. 2001;116:853–859
  28. Hajitou A, Sounni NE, Devy L, Grignet-Debrus C, Lewalle JM, Li H, et al. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Cancer Res. 2001;61:3450–3457
  29. Deroanne CF, Bonjean K, Servotte S, Devy L, Colige A, Clausse N, et al. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene. 2002;21:427–436
  30. Creamer D, Allen MH, Sousa A, Poston R, Barker JN. Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis. Br J Dermatol. 1997;136:859–865
  31. Halin C, Detmar M. Chapter 1. Inflammation, angiogenesis, and lymphangiogenesis. Methods Enzymol. 2008;445:1–25
  32. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol. 2005;166:913–921
  33. Hong YK, Lange-Asschenfeldt B, Velasco P, Hirakawa S, Kunstfeld R, Brown LF, et al. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J. 2004;18:1111–1113
  34. Man XY, Yang XH, Cai SQ, Yao YG, Zheng M. Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Mol Med. 2006;12:127–136
  35. Petrova TV, Bono P, Holnthoner W, Chesnes J, Pytowski B, Sihto H, et al. VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors. Cancer Cell. 2008;13:554–556
  36. Karpanen T, Wirzenius M, Makinen T, Veikkola T, Haisma HJ, Achen MG, et al. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am J Pathol. 2006;169:708–718
  37. Lee JH, Cho EY, Namkung JH, Kim E, Kim S, Shin ES, et al. Single-nucleotide polymorphisms and haplotypes in the VEGF receptor 3 gene and the haplotype GC in the VEGFA gene are associated with psoriasis in Koreans. J Invest Dermatol. 2008;128:1599–1603
  38. Ruhrberg C, Gerhardt H, Golding M, Watson R, Ioannidou S, Fujisawa H, et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 2002;16:2684–2698
  39. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389–395
  40. Braverman IM, Sibley J. Role of the microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol. 1982;78:12–17
  41. Ancelin M, Chollet-Martin S, Herve MA, Legrand C, El Benna J, Perrot-Applanat M. Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism. Lab Invest. 2004;84:502–512
  42. Watari K, Nakao S, Fotovati A, Basaki Y, Hosoi F, Bereczky B, et al. Role of macrophages in inflammatory lymphangiogenesis: enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. Biochem Biophys Res Commun. 2008;377:826–831
  43. Hamrah P, Chen L, Zhang Q, Dana MR. Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am J Pathol. 2003;163:57–68
  44. Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, Richard L, et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol. 1998;111:1–6
  45. Teoh D, Johnson LA, Hanke T, McMichael AJ, Jackson DG. Blocking development of a CD8+ T cell response by targeting lymphatic recruitment of APC. J Immunol. 2009;182:2425–2431
  46. Kataru RP, Jung K, Jang C, Yang H, Schwendener RA, Baik JE, et al. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood. 2009;113:5650–5659

PII: S0923-1811(09)00368-5

doi: 10.1016/j.jdermsci.2009.12.006

« Back Journal of Dermatological Science

Article in Press

Article Tools

* Image Usage & Resolution